Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
South Korea — Bank of Korea policy rate decision on May 28: 2.50%; market expected 2.50%; prior 2.50%.
2026-05-28
South Korea — Bank of Korea policy rate decision on May 28: 2.50%; market expected 2.50%; prior 2.50%.
Back
Other News
2026-05-28
At a May 28 regular press briefing, the Ministry of Natural Resources published and explained the Guiding Opinions on Accelerating High-Quality Development of Marine Drugs and Functional Products. On intellectual property protection, Yu Jiangyong, de
At a May 28 regular press briefing, the Ministry of Natural Resources published and explained the Guiding Opinions on Accelerating High-Quality Development of Marine Drugs and Functional Products. On intellectual property protection, Yu Jiangyong, deputy director of the Drugs Registration Management Department at the National Medical Products Administration (NMPA), said the NMPA and the China National Intellectual Property Administration (CNIPA) has established an early-resolution mechanism for drug patent disputes. The newly revised Implementing Regulations of the PRC Drug Administration Law (the Regulations) further strengthen protection for drug trial data and establish a market exclusivity-period system for pediatric medicines and drugs for rare diseases. The Measures for the Protection of Drug Trial Data took effect simultaneously with the Regulations on May 15, and the Regulations’ specific implementation documents for the market exclusivity system are currently being intensively drafted. NMPA said these measures will further bolster IP protection for innovative drugs and stimulation firms’ innovation momentum in marine drug R&D.
2026-05-28
New Zealand Treasury expects net debt to be 42.4% of GDP in the 2025/26 fiscal year.
New Zealand Treasury expects net debt to be 42.4% of GDP in the 2025/26 fiscal year.
Chat with us
, powered by
LiveChat